"MEDCHEMEXPRESS"
Atabecestat 10mg AZ14311752 1 * 10 mg
Supplier: MEDCHEMEXPRESS
Atabecestat 10mg AZ14311752 1 * 10 mg
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: 10 MM IN DMSO
MK-5172 IS A NOVEL P2-P4 QUINOXALINE MACROCYCLIC HCV NS3/4A PROTEA SE INHIBITOR CURRENTLY IN CLINICAL DEVELOPMENT.IC50 VALUE: 7.4 NM AND 7 NM FOR GENOTYPE 1B AND 1A RESPECTIVELY, IN RE 1 * 1 mL
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: 10 MM IN DMSO
MK-5172 IS A NOVEL P2-P4 QUINOXALINE MACROCYCLIC HCV NS3/4A PROTEA SE INHIBITOR CURRENTLY IN CLINICAL DEVELOPMENT.IC50 VALUE: 7.4 NM AND 7 NM FOR GENOTYPE 1B AND 1A RESPECTIVELY, IN RE 1 * 1 mL
Expand 1 Items
Deucravacitinib 1 * 200 mg
Supplier: MEDCHEMEXPRESS
Deucravacitinib 1 * 200 mg
Expand 1 Items
Bavdegalutamide 1 * 100 mg
Supplier: MEDCHEMEXPRESS
Bavdegalutamide 1 * 100 mg
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO >20 MG/ML
UK-5099(PF1005023) IS A POTENT INHIBITOR OF PLASMA MEMBRANE MONOC ARBOXYLATE TRANSPORTERS (MCTS) AND THE MITOCHONDRIAL PYRUVATE CARRIER (MPC) INHIBITS PYRUVATE-DEPENDENT O2 CONSUMPTI 1 * 1 mL
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO >20 MG/ML
UK-5099(PF1005023) IS A POTENT INHIBITOR OF PLASMA MEMBRANE MONOC ARBOXYLATE TRANSPORTERS (MCTS) AND THE MITOCHONDRIAL PYRUVATE CARRIER (MPC) INHIBITS PYRUVATE-DEPENDENT O2 CONSUMPTI 1 * 1 mL
Expand 1 Items
Citarinostat (HDAC6 inhibitor) 1 * 10 mg
Supplier: MEDCHEMEXPRESS
Citarinostat (HDAC6 inhibitor) 1 * 10 mg
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: 10 MM IN DMSO
SAR7334 IS A NOVEL AND POTENT TRCP6 INHIBITOR FROM PCT INT. APPL. (2011), WO 2011107474 A1 20110909. 1 * 5 mg
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: 10 MM IN DMSO
SAR7334 IS A NOVEL AND POTENT TRCP6 INHIBITOR FROM PCT INT. APPL. (2011), WO 2011107474 A1 20110909. 1 * 5 mg
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO: ≥ 5 MG/ML, H2O: < 4.9 MG/ML
UNC2025 IS A POTENT AND ORALLY BIOAVAILABLE ME R/FLT3 DUAL INHIBITOR WITH IC50 OF 0.8/0.74 NM FOR MER/FLT3.IC50 VALUE: 0.8/0.74 NM(MER/FLT3)TARGET: MER/FLT3 INHIBIT 1 * 5 mg
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO: ≥ 5 MG/ML, H2O: < 4.9 MG/ML
UNC2025 IS A POTENT AND ORALLY BIOAVAILABLE ME R/FLT3 DUAL INHIBITOR WITH IC50 OF 0.8/0.74 NM FOR MER/FLT3.IC50 VALUE: 0.8/0.74 NM(MER/FLT3)TARGET: MER/FLT3 INHIBIT 1 * 5 mg
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: 10 MM IN DMSO
VILANTEROL TRIFENATATE (GW642444)IS A NOVEL, INHALED, LONG-ACTING Β(2) AGONIST WITH INHERENT 24-H ACTIVITY UNDER DEVELOPMENT AS A ONCE-DAILY COMBINATION THERAPY WITH AN INHALED CORTICO 1 * 100 mg
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: 10 MM IN DMSO
VILANTEROL TRIFENATATE (GW642444)IS A NOVEL, INHALED, LONG-ACTING Β(2) AGONIST WITH INHERENT 24-H ACTIVITY UNDER DEVELOPMENT AS A ONCE-DAILY COMBINATION THERAPY WITH AN INHALED CORTICO 1 * 100 mg
Expand 1 Items
SOLUBILITY: DMSO ≥ 26 MG/ML
FCCP IS AN UNCOUPLER OF OXIDATIVE PHOSPHORYLATION IN MITOCHONDRIA. 1 * 10 mg
Supplier: MEDCHEMEXPRESS
SOLUBILITY: DMSO ≥ 26 MG/ML
FCCP IS AN UNCOUPLER OF OXIDATIVE PHOSPHORYLATION IN MITOCHONDRIA. 1 * 10 mg
Expand 1 Items
AP1867-2-(carboxymethoxy) 1 * 5 mg
Supplier: MEDCHEMEXPRESS
AP1867-2-(carboxymethoxy) 1 * 5 mg



